secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001104659-22-067626
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio stockholders elect all three Class III directors and ratify KPMG as auditor
--------------------------------------------------------------------------------

- Vince Burgess, Federica O'Brien, and John Nosenzo elected as Class III directors with >10.7M votes each.
- Ratification of KPMG LLP as independent auditor passed with 13,084,355 votes for, 124,770 against.
- Annual Meeting held virtually on June 1, 2022; 14,556,750 shares outstanding as of record date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922067626/0001104659-22-067626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465922067626/tm2217511d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-067626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer